Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
389.8 USD | -1.96% | +4.13% | +27.16% |
Apr. 24 | Baird Adjusts Medpace Price Target to $454 From $446, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Medpace Holdings, Inc., Q1 2024 Earnings Call, Apr 23, 2024 |
Financials (USD)
Sales 2024 * | 2.17B | Sales 2025 * | 2.52B | Capitalization | 12.05B |
---|---|---|---|---|---|
Net income 2024 * | 360M | Net income 2025 * | 418M | EV / Sales 2024 * | 5.22 x |
Net cash position 2024 * | 715M | Net cash position 2025 * | 1.04B | EV / Sales 2025 * | 4.37 x |
P/E ratio 2024 * |
34.9
x | P/E ratio 2025 * |
29.7
x | Employees | 5,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.84% |
Latest transcript on Medpace Holdings, Inc.
1 day | -1.96% | ||
1 week | +4.13% | ||
Current month | -3.56% | ||
1 month | -3.11% | ||
3 months | +31.04% | ||
6 months | +50.77% | ||
Current year | +27.16% |
Managers | Title | Age | Since |
---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 67 | 92-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 49 | 18-10-31 |
Jesse Geiger
PSD | President | 49 | 07-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Davenport
BRD | Director/Board Member | 72 | 18-08-12 |
August Troendle
CEO | Chief Executive Officer | 67 | 92-06-30 |
Director/Board Member | 64 | 18-08-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.15% | 2 M€ | -.--% | ||
0.49% | 0 M€ | 0.00% | - | |
0.40% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 389.8 | -1.96% | 313,834 |
24-04-24 | 397.6 | -2.36% | 423,451 |
24-04-23 | 407.2 | +8.21% | 808,514 |
24-04-22 | 376.3 | +1.15% | 357,745 |
24-04-19 | 372 | -0.62% | 221,668 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.16% | 12.05B | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.64% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+7.30% | 11.1B | |
-18.79% | 9.85B |
- Stock Market
- Equities
- MEDP Stock